St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B (Alaric DeArment/MedCity News)

Alaric DeArment / MedCity News:
St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B  —  The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs.